Pharmaceuticals & Healthcare – Upcoming & Recent Reports

OpportunityAnalyzer: Ovarian Cancer – Opportunity Analysis and Forecasts to 2025

Ovarian cancer is the fifth most common malignancy in women and is the leading cause of death amongst gynecological cancers. Due to the nonspecific nature of disease symptoms, the majority of ovarian cancer patients are diagnosed with advanced-…

Published: May’ 2017       Format: Electronic PDF       Pricing: $10,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals

The pharmaceutical and healthcare industry reported an increase in the number of deals and a decrease in deal values in March 2017. The industry reported 378 deals worth USD13.6 billion in March 2017, compared to 303 deals worth USD19.4 billio…

Published: May’ 2017       Format: Electronic PDF       Pricing: $1,000

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


EpiCast Report: Cystic Fibrosis – Epidemiology Forecast to 2025

Cystic fibrosis (CF) is an inherited disorder that affects the cells that produce mucus, sweat, and digestive juices, causing severe damage to the lungs, digestive system, and other organs. In CF patients, a defective gene results in sticky and…

Published: April’ 2017       Format: Electronic PDF       Pricing: $3,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


OpportunityAnalyzer: Bladder Cancer – Opportunity Analysis and Forecasts to 2025

The bladder cancer market in the seven major pharmaceutical markets (US, France, Germany, Italy, Spain, UK, and Japan) has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the…

Published: April’ 2017       Format: Electronic PDF       Pricing: $10,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


PharmSource – M&A in the CMC Services Industry: Implications and Outlook

M&A is reshaping the bio/pharmaceutical contract development services industry. Established CMOs and CROs are pursuing acquisitions to drive scale and broaden their offerings, while private equity are anxious to either gain a presence in th…

Published: April’ 2017       Format: Electronic PDF       Pricing: $2,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


PharmaPoint: Human Immunodeficiency Virus (HIV) – Global Drug Forecast and Market Analysis to 2025

Human immunodeficiency virus (HIV) is a retrovirus that infects the cells of the immune system, destroying or impairing their function. As the infection progresses, the immune system becomes increasingly weaker, making the infected person more …

Published: April’ 2017       Format: Electronic PDF       Pricing: $10,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


OpportunityAnalyzer: Cystic Fibrosis – Opportunity Analysis and Forecasts to 2025

Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which codes for the CFTR protein. As a multisystem condition, CF patients show great heterogeneit…

Published: April’ 2017       Format: Electronic PDF       Pricing: $10,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2016

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in Q4 2016 with 986 deals worth USD81.7 billion, as compared 1,194 worth USD85.9 billion in Q4 2015. On a quarter-on-quarter basis, the number…

Published: April’ 2017       Format: Electronic PDF       Pricing: $1,500

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Spain

Latest report: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Spain. The report is an essential source of information on and analysis of the healthcare, regulator…

Published: April’ 2017       Format: Electronic PDF       Pricing: $1,995

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Partnerships, Licensing, Investments and M&A Deals and Trends for February 2017 in Pharmaceuticals

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in February 2017. The industry reported 302 deals worth USD19.4 billion in February 2017, compared to 342 deals worth USD57.4 billion in Janua…

Published: April’ 2017       Format: Electronic PDF       Pricing: $1,000

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017

Clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017″ provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinic…

Published: March’ 2017       Format: Electronic PDF       Pricing: $2,500

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Acute Stress Disorder Global Clinical Trials Review, H1, 2017

Clinical trial report, “Acute Stress Disorder Global Clinical Trials Review, H1, 2017″ provides an overview of Acute Stress Disorder clinical trials scenario. This report provides top line data relating to the clinical tri…

Published: March’ 2017       Format: Electronic PDF       Pricing: $2,500

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017

Clinical trial report, “Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017″ provides an overview of Acute Upper Respiratory Tract Infections clinical trials scenario. This report provides top …

Published: March’ 2017       Format: Electronic PDF       Pricing: $2,500

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Addison’s Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017

Clinical trial report, “Addison’s Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017″ provides an overview of Addison’s Disease (Primary or Chronic Adrenal Insufficiency) cli…

Published: March’ 2017       Format: Electronic PDF       Pricing: $2,500

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us


Adrenal Insufficiency Global Clinical Trials Review, H1, 2017

Clinical trial report, “Adrenal Insufficiency Global Clinical Trials Review, H1, 2017″ provides an overview of Adrenal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical tri…

Published: March’ 2017       Format: Electronic PDF       Pricing: $2,500

For Detailed Summary, Sample Pages or to procure a Copy, please feel free to Contact Us

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Create a free website or blog at WordPress.com.

Up ↑

%d bloggers like this: